Global Candidiasis Drugs Market 2019-2023Posted by Melisa on August 7th, 2019 The global candidiasis drugs market is expected to post a CAGR close to 4% during the period 2019-2023, according to the latest market research report by Technavio. The signs and symptoms of candidiasis are very broad, and they also depend on the type of candidiasis infection. Therefore, to create awareness about the disease and treatment options and avoid delay in diagnosis, the CDC is providing information about candidiasis, and its causes, risk factors, transmission, diagnosis, and treatment. Furthermore, several organizations are providing free access to online health information to prevent various diseases and minimize the effects of ongoing health conditions, including candidiasis, Hence, the increase in the number of organizations and institutes that create awareness about candidiasis among people is expected to drive the growth of the global candidiasis drugs market during the forecast period. Global candidiasis drugs market: Advances in diagnosis of antifungal-resistant pathogens Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop the ability to defend these drugs and can cause serious bloodstream infections in hospitalized patients. Hence, advanced technologies where the system uses a technology called matrix-assisted laser desorption/ionization (MALDI-TOF) mass spectrometry, in combination with the reference organism database. In this technique, microorganisms, which are cultured from patient samples are ionized by the laser to produce a spectrum of microorganisms, which are matching with the spectrum of reference microorganism database to identify the microorganisms. Such technologies are expected to improve the diagnosis further in coming years, which support the market growth during the forecast period through early confirmation of the disease for the treatment. “Apart from the advances in the diagnosis of anti-fungal-resistant pathogens, the provision of special regulatory designations, the high-risk factors of candidiasis and strategic alliances are some other major factors boosting the growth of the global market,” says a senior analyst at Technavio. Global candidiasis drugs market: Segmentation analysis This market research report segments the global candidiasis drugs market by type (azoles, echinocandins, other drugs) and geographical regions (North America, Europe, Asia, and ROW). The North American region led the market in 2018, followed by North America, APAC, South America, and MEA respectively. However, during the forecast period, the APAC region is expected to register the highest incremental growth due to the rising awareness about diagnosis and management of invasive fungal infections. Some of the key topics covered in the report include: Market Landscape
Market Sizing
Five Forces Analysis Market Segmentation Geographical Segmentation
Market Drivers Market Challenges Market Trends Vendor Landscape
About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Like it? Share it! More by this author |